EUVIMEDEUVIMED entdecken
Open Access

Cenobamate suppresses seizures without inducing cell death in neonatal rats

Eric Witherspoon, Gabrielle Williams, Nicholas Zuczek, Patrick A Forcelli

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Eric Witherspoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA. Hauptthemen laut MEDLINE: Animals, Newborn, Seizures, Anticonvulsants, Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, NICHD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GABA modulators such as phenobarbital (PB) and sodium channel blockers such as phenytoin (PHT) have long been the mainstay of pharmacotherapy for the epilepsies. In the context of neonatal seizures, both PB and PHT display incomplete clinical efficacy. Moreover, in animal models, neonatal exposure to these medications result in neurodegeneration raising concerns about safety. Cenobamate, a more recently approved medication, displays unique pharmacology as it is both a positive allosteric modulator of GABA-A receptors, and a voltage-gated sodium channel blocker. While cenobamate is approved for adult use, its efficacy and safety profile against neonatal seizures is poorly understood. To address this gap, we assessed the efficacy and safety of cenobamate in immature rodents. Postnatal day (P)7 rat pups were pretreated with cenobamate and challenged with the chemoconvulsant pentylenetetrazole (PTZ) to screen for anti-seizure effects. In a separate experiment, P7 rats were treated with cenobamate, and brains were processed to assess induction of cell death. Cenobamate displays dose-dependent anti-seizure efficacy in neonatal rats. Unlike PHB and PHT, it does not induce neurotoxicity in P7 rats. Thus, cenobamate may be effective at treating neonatal seizures while avoiding unwanted neurotoxic side effects such as cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Animals, NewbornSeizuresAnticonvulsantsRats, Sprague-DawleyCell DeathCarbamatesDisease Models, AnimalDose-Response Relationship, DrugAnimalsRatsChlorophenolsPentylenetetrazoleMaleFemaleConvulsantsBrainTetrazoles

Stichwörter der Autor:innen

ApoptosisCell-deathCenobamateEpilepsyNeonatalPentylenetetrazole

Substanzen

AnticonvulsantsCenobamateCarbamatesChlorophenolsPentylenetetrazoleConvulsantsTetrazoles

Autor:innen und Institutionen

  • Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA.
  • Department of Pharmacology & Physiology, Georgetown University, Washington, DC, USA; Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC, USA; Department of Neuroscience, Georgetown Universi…

Förderung

  • NICHD NIH HHS
  • NIGMS NIH HHS
  • NICHD
  • National Institutes of Health
  • NIGMS

Zitieren

APA

Witherspoon, E., Williams, G., Zuczek, N., & Forcelli, P. A. (2024). Cenobamate suppresses seizures without inducing cell death in neonatal rats. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109898

Vancouver

Witherspoon E, Williams G, Zuczek N, Forcelli PA. Cenobamate suppresses seizures without inducing cell death in neonatal rats. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109898

BibTeX
@article{Witherspoon2024,
  author = {Witherspoon, Eric and Williams, Gabrielle and Zuczek, Nicholas and Forcelli, Patrick A},
  title = {Cenobamate suppresses seizures without inducing cell death in neonatal rats},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109898}
}
Kostenlos starten →